UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $90.00

Colgate-Palmolive (NYSE:CL) had its price objective lowered by investment analysts at UBS Group from $92.00 to $90.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price target indicates a potential upside of 20.10% from the stock’s current price.

A number of other analysts have also recently weighed in on the stock. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a report on Monday. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating for the company in a research note on Monday. The Goldman Sachs Group decreased their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Raymond James Financial decreased their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $90.00.

Colgate-Palmolive Price Performance

NYSE:CL traded down $2.11 during trading hours on Monday, reaching $74.94. 10,801,867 shares of the company’s stock were exchanged, compared to its average volume of 5,446,842. The company has a market capitalization of $60.56 billion, a P/E ratio of 21.05, a price-to-earnings-growth ratio of 4.44 and a beta of 0.34. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $100.18. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The business’s 50-day simple moving average is $80.45 and its two-hundred day simple moving average is $86.28.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period last year, the firm posted $0.91 earnings per share. Sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Institutional Investors Weigh In On Colgate-Palmolive

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Summit Global Investments lifted its position in Colgate-Palmolive by 17.9% in the 3rd quarter. Summit Global Investments now owns 207,219 shares of the company’s stock worth $16,565,000 after buying an additional 31,509 shares in the last quarter. Golden State Wealth Management LLC raised its holdings in shares of Colgate-Palmolive by 703.5% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,149 shares of the company’s stock valued at $92,000 after purchasing an additional 1,006 shares in the last quarter. Foundations Investment Advisors LLC raised its holdings in shares of Colgate-Palmolive by 27.6% during the 3rd quarter. Foundations Investment Advisors LLC now owns 6,357 shares of the company’s stock valued at $508,000 after purchasing an additional 1,375 shares in the last quarter. Cloud Capital Management LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $30,000. Finally, AE Wealth Management LLC raised its holdings in shares of Colgate-Palmolive by 25.9% during the 3rd quarter. AE Wealth Management LLC now owns 15,163 shares of the company’s stock valued at $1,212,000 after purchasing an additional 3,115 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.